BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9723164)

  • 1. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Côté F; Julien JP
    Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
    Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
    Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL(+/+) and NFL(-/-) mice.
    McLean JR; Sanelli TR; Leystra-Lantz C; He BP; Strong MJ
    Glia; 2005 Oct; 52(1):59-69. PubMed ID: 15920739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple test to monitor the motor dysfunction in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Julien JP
    J Psychiatry Neurosci; 1995 Jan; 20(1):80-2. PubMed ID: 7865504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant mice, Cu,Zn superoxide dismutase, and motor neuron degeneration.
    McCord JM
    Science; 1994 Dec; 266(5190):1586-7. PubMed ID: 7985031
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis.
    Vechio JD; Bruijn LI; Xu Z; Brown RH; Cleveland DW
    Ann Neurol; 1996 Oct; 40(4):603-10. PubMed ID: 8871580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Curr Mol Med; 2009 Apr; 9(3):255-72. PubMed ID: 19355908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amyotrophic lateral sclerosis and superoxide dismutase--a review].
    Binzer MN; Gredal O; Brøndum-Nielsen K; Andersen PM
    Ugeskr Laeger; 1997 Mar; 159(11):1593-6. PubMed ID: 9092140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and selective pathology of light chain neurofilament in the spinal cord and sciatic nerve of G86R mutant superoxide dismutase transgenic mice.
    Morrison BM; Shu IW; Wilcox AL; Gordon JW; Morrison JH
    Exp Neurol; 2000 Oct; 165(2):207-20. PubMed ID: 10993681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of ALS.
    Pioro EP; Mitsumoto H
    Clin Neurosci; 1995-1996; 3(6):375-85. PubMed ID: 9021259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis.
    Miyazaki K; Ohta Y; Nagai M; Morimoto N; Kurata T; Takehisa Y; Ikeda Y; Matsuura T; Abe K
    J Neurosci Res; 2011 May; 89(5):718-28. PubMed ID: 21337372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
    Dupuis L; Loeffler JP
    Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis.
    Jackson CE; Bryan WW
    Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.
    Nguyen MD; Larivière RC; Julien JP
    Neuron; 2001 Apr; 30(1):135-47. PubMed ID: 11343650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.